Inhibition of the MAPK/ERK signaling cascade by MEK inhibitors and ERK inhibitors in human neuroendocrine tumor cell lines in vitro demonstrates potent antiproliferative effects. Here, MAP2K7 is linked to neuroendocrine neoplasm.